Question 1

What is 4D Molecular Therapeutics?

Accepted Answer

4D Molecular Therapeutics is a Company.

Question 2

How often does 4D Molecular Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was 4D Molecular Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 26, 2026.

Question 4

When was 4D Molecular Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 30, 2026.

Question 5

What is 4D Molecular Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 10 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is 4D Molecular Therapeutics in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving 4D Molecular Therapeutics?

Accepted Answer

4D_Molecular_Therapeutics Presents 4D-150 Data (Jun 30, 2026, 6 articles).

Question 8

How did the "4D_Molecular_Therapeutics Presents 4D-150 Data" event impact 4D Molecular Therapeutics?

Accepted Answer

4D Molecular Therapeutics announced a podium presentation at the 44th Annual Scientific Meeting of the American Society of Retina Specialists, showcasing its investigational gene therapy 4D-150. This presentation could increase visibility and investor interest in the company's pipeline.

Question 9

How did the "Vivani Medical Board Changes" event impact 4D Molecular Therapeutics?

Accepted Answer

August Moretti previously served as the Chief Financial Officer of 4D Molecular Therapeutics, providing him with relevant experience for his new role at Vivani Medical.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.